Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP926564.RA3RimxWRB5z3xfcySFbMLUv0-IAg9Nc-Ra2i4Bf4rVnk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP926564.RA3RimxWRB5z3xfcySFbMLUv0-IAg9Nc-Ra2i4Bf4rVnk130_assertion type Assertion NP926564.RA3RimxWRB5z3xfcySFbMLUv0-IAg9Nc-Ra2i4Bf4rVnk130_head.
- NP926564.RA3RimxWRB5z3xfcySFbMLUv0-IAg9Nc-Ra2i4Bf4rVnk130_assertion description "[Our data suggest that transactivation of CDCA5 and its phosphorylation at Ser209 by ERK play an important role in lung cancer proliferation, and that the selective suppression of the ERK-CDCA5 pathway could be a promising strategy for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926564.RA3RimxWRB5z3xfcySFbMLUv0-IAg9Nc-Ra2i4Bf4rVnk130_provenance.
- NP926564.RA3RimxWRB5z3xfcySFbMLUv0-IAg9Nc-Ra2i4Bf4rVnk130_assertion evidence source_evidence_literature NP926564.RA3RimxWRB5z3xfcySFbMLUv0-IAg9Nc-Ra2i4Bf4rVnk130_provenance.
- NP926564.RA3RimxWRB5z3xfcySFbMLUv0-IAg9Nc-Ra2i4Bf4rVnk130_assertion SIO_000772 20551060 NP926564.RA3RimxWRB5z3xfcySFbMLUv0-IAg9Nc-Ra2i4Bf4rVnk130_provenance.
- NP926564.RA3RimxWRB5z3xfcySFbMLUv0-IAg9Nc-Ra2i4Bf4rVnk130_assertion wasDerivedFrom befree-20140225 NP926564.RA3RimxWRB5z3xfcySFbMLUv0-IAg9Nc-Ra2i4Bf4rVnk130_provenance.
- NP926564.RA3RimxWRB5z3xfcySFbMLUv0-IAg9Nc-Ra2i4Bf4rVnk130_assertion wasGeneratedBy ECO_0000203 NP926564.RA3RimxWRB5z3xfcySFbMLUv0-IAg9Nc-Ra2i4Bf4rVnk130_provenance.